Trial Profile

Phase IV Study of DCE-MRI Using Dotarem in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC.

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 12 Aug 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Gadoterate-meglumine (Primary)
Indications Liver cancer
Focus Diagnostic use
Acronyms DCE-MRI
Sponsors Guerbet

Most Recent Events

24 Jun 2019 Status changed from active, no longer recruiting to discontinued.
05 Mar 2018 Planned End Date changed from 1 Oct 2017 to 1 Apr 2018.
23 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Oct 2017.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com